Introduction to DF-Nu503 in vivo nuclide residue detector video

Monitoring system for residual radionuclide therapy in discharged patientsDF-Nu503A,The nuclear therapy monitoring system includes a nuclear therapy monitor and a nuclear therapy monitoring software, which can measure the residual drug activity in the body of nuclear therapy patients and assist the department in the discharge control of nuclear therapy patients. The radionuclide therapy monitoring device uses a highly sensitive scintillation detector to quickly measure the iodine-131 activity in the patient's body over a wide range of activities. It is equipped with video surveillance and voice communication to monitor the patient's testing process in real time. The test data is transmitted to the radionuclide therapy monitoring software through Ethernet, which detects residual activity in the patient's body. The patient can be discharged if the activity is within the specified value.

Monitoring system for residual radionuclide therapy in discharged patientsDF-Nu503A Technical Performance:

Activity measurement range: 0.1mCi~500mCi

Detection accuracy: ± 10%

Sensitivity of detection: 30CPS@Cs-137

Detection source type: 35keV -1.5MeV

Detector technology category: scintillation crystal+SiPM

Size: 353 * 249 * 86mm;

Instrument features:

Durable and stable, with an exquisite appearance

Network monitoring, remote voice communication

Sv, CPS multi unit display

Scintillation detector, high performance, fast response

Quick quantification

Stay away from radiation

Notes:

All interfaces cannot be plugged in or unplugged with power on;

This instrument belongs to precision measuring instruments and should avoid collisions and drops;

If the instrument is not used for a long time, please turn off the power and store the instrument in a dry and normal temperature environment;

Non personnel are not allowed to disassemble instruments or open components;

If the instrument malfunctions, it needs to be handled by technical personnel.